SecBot SecBot
144 ·Filed Nov 9, 2026

DNTH

Dianthus Therapeutics, Inc. /DE/
NEUTRAL
Impact 3/10
Horizonweeks Processed7d 7h ago SEC0001950047-26-010869
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The Form 144 signals intent to sell, but the sale may not be executed. Monitor subsequent Form 4 filings to confirm actual sales. The officer's option exercise and sale plan could indicate a desire to diversify or raise cash, but the amount is modest relative to market cap.

DirectionNeutral
Confidencemedium
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$88.81
T+0 close · Nov 9, 2026 · via day close
Latest settled
+0.55%
T+1 · $89.30
Vs SPY
−0.77%
α at T+1
Next horizon
T+5
in 7h
  1. T+0 · Nov 10 $88.81entry
  2. T+1 · 6d ago +0.55%α −0.77% · $89.30
  3. T+4 · todayOpen
  4. T+5 · in 7h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Ryan Savitz, an officer of Dianthus Therapeutics, filed a Form 144 notice of intent to sell 124,042 shares of common stock, with an approximate market value of $10.7 million based on the filing. The shares are to be acquired through the exercise of stock options over the next three months. This represents a notable insider sale relative to the company's $4.7B market cap.

Key Facts

  • Filer: Ryan Savitz, an officer of Dianthus Therapeutics
  • Shares to be sold: 124,042 shares of common stock
  • Approximate market value: $10,671,333.26
  • Shares to be acquired via exercise of stock options over the next three months
  • Filing date: November 9, 2026
  • Company market cap: $4.7B

Financial Impact

Sale of 124,042 shares valued at approximately $10.7 million, representing about 0.23% of market cap

dilution

Risk Factors

  • Insider sale may signal reduced conviction or need for liquidity
  • Sale may not occur; Form 144 is only an intent to sell
  • No specific sale date or price provided beyond the filing date

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
96% bullish (24 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010869
Document: 0001950047-26-010869-index.html0001950047-26-010869
Document: 0001950047-26-010869.txt0001950047-26-010869

Track record

23 reports on DNTH

Performance horizon

7 of 8 bullish or bearish reports moved the stock their way by T+1. Best: +41.40% at T+60 after the Jun 11, 2026 report. 8 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $89.76 Now $89.55 −0.23% settles Nov 17
  2. Nov 9, 20267d ago 144 Neutral 3/10 Viewing Entry $88.81 to $89.30 Now $89.55 +0.83% ▲ +0.55% −0.77% vs SPY
  3. Nov 4, 202612d ago 8-K Neutral 4/10 No price data
  4. Nov 4, 202612d ago Press Release Neutral 4/10 Entry $83.01 to $86.03 Now $89.55 +7.88% ▲ +3.64% +3.33% vs SPY
  5. Oct 30, 202617d ago Institutional Cluster Neutral 3/10 Entry $82.38 to $82.25 Now $89.55 +8.70% ▼ −0.16% +0.32% vs SPY
  6. Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $82.38 to $82.25 Now $89.55 +8.70% ▼ −0.16% +0.32% vs SPY
  7. Oct 12, 20265w ago Institutional Cluster Mixed 3/10 Entry $81.57 to $77.58 Now $89.55 +9.78% ▼ −4.89% −4.88% vs SPY
  8. Aug 11, 202613w ago Insider Cluster Neutral 4/10 Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
  9. Aug 11, 202613w ago Insider Cluster Neutral 3/10 Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
  10. Aug 11, 202613w ago Insider Cluster Neutral 3/10 Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens Wed (9h 36m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 9, 2026